Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo

Fig. 5

Effects on the CT26 tumours for the negative control, AF2240-i, and rAF-IL12 groups. a Images of CT26 tumour harvested from negative control, AF2240-i, and rAF-IL12 groups following the 28-days of treatment. b The growth rate of the CT26 tumours from day-0 until day-28 of treatments. c Average weight of CT26 tumours harvested from mice after 28-days of treatment. Data are represented as mean ± S.E.M. of six mice per group. Mean values with statistical difference at p < 0.05 between control, AF2240-i, and rAF-IL12 are indicated with *

Back to article page